Literature DB >> 25227077

Oscillating field stimulation promotes spinal cord remyelination by inducing differentiation of oligodendrocyte precursor cells after spinal cord injury.

Cheng Zhang1, Guanghao Zhang1, Wei Rong2, Aihua Wang1, Changzhe Wu1, Xiaolin Huo1.   

Abstract

Demyelination is part of the cascading secondary injury after the primary insult and contributes to the loss of function after spinal cord injury (SCI). Oligodendrocyte precursor cells (OPCs) are the main remyelinating cells in the central nervous system (CNS). We explored whether oscillating field stimulation (OFS) could efficiently promote OPC differentiation and improve remyelination after SCI. SD rats with SCI induced by the Allen method were randomly divided into two groups, the SCI+OFS group and SCI group. The former group received active stimulator units and the latter group received sham (inoperative) stimulator units. Additionally, rats that only received laminectomy were referred as the sham group. The electric field intensity was 600 μV/mm, and the polarity was alternated every 15 minutes. The results showed that the SCI+OFS rats had significantly less demyelination and better locomotor function recovery after 12-weeks treatment. The OFS treatment significantly increased the number of Gal C-positive OPCs after 2-weeks treatment. Furthermore, these rats had higher protein expression of oligodendroglial transcription factors Olig2 and NKx2.2. These findings suggest OFS can promote locomotor recovery and remyelination in SCI rats and this effect may be related to the improved differentiation of OPCs in the spinal cord.

Entities:  

Keywords:  Oligodendrocyte precursor cells; oscillating field stimulation; rat; remyelination; spinal cord injury

Mesh:

Year:  2014        PMID: 25227077     DOI: 10.3233/BME-141190

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  8 in total

Review 1.  The axon-glia unit in white matter stroke: mechanisms of damage and recovery.

Authors:  Shira Rosenzweig; S Thomas Carmichael
Journal:  Brain Res       Date:  2015-02-20       Impact factor: 3.252

Review 2.  Electrical stimulation for neuroregeneration in urology: a new therapeutic paradigm.

Authors:  Brian M Balog; Kangli Deng; Vinod Labhasetwar; Kathryn J Jones; Margot S Damaser
Journal:  Curr Opin Urol       Date:  2019-07       Impact factor: 2.309

3.  Epidural oscillating field stimulation increases axonal regenerative capacity and myelination after spinal cord trauma.

Authors:  Maria Bacova; Katarina Bimbova; Alexandra Kisucka; Nadezda Lukacova; Jan Galik
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

4.  Oscillating field stimulation promotes axon regeneration and locomotor recovery after spinal cord injury.

Authors:  Yi-Xin Wang; Jin-Zhu Bai; Zhen Lyu; Guang-Hao Zhang; Xiao-Lin Huo
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

Review 5.  Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.

Authors:  Andrea Salazar-Camelo; Naveen George; Hesham Abboud; Sarah M Planchon; Marcelo Matiello; Maureen A Mealy; Andrew Goodman
Journal:  J Neurol       Date:  2021-09-05       Impact factor: 4.849

Review 6.  Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.

Authors:  Ning Li; Gilberto K K Leung
Journal:  Biomed Res Int       Date:  2015-09-27       Impact factor: 3.411

7.  Effect of electrical stimulation on neural regeneration via the p38-RhoA and ERK1/2-Bcl-2 pathways in spinal cord-injured rats.

Authors:  Min Cheol Joo; Chul Hwan Jang; Jong Tae Park; Seung Won Choi; Seungil Ro; Min Seob Kim; Moon Young Lee
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

Review 8.  Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury.

Authors:  Nadezda Lukacova; Alexandra Kisucka; Katarina Kiss Bimbova; Maria Bacova; Maria Ileninova; Tomas Kuruc; Jan Galik
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.